Navigation Links
NJIT receives patent today for new shunt to aid brain-injured patients
Date:1/3/2012

NJIT Professor Gordon Thomas and NJIT Research Professor Reginald Farrow, both in the department of physics, and NJIT alumnus Sheng Liu, formerly a doctoral student of both researchers and now an engineer at a biotech company, were awarded a patent today for the NJIT SmartShunt, a unique device to help patients with brain injuries.

The patent, entitled "No Clog Shunt Using a Compact Fluid Drag Path" (US Patent Number 8,088,091), discloses a device that enables the non-invasive wireless monitoring of both the extremely slow flow of cerebrospinal fluid as well as tiny changes in pressure in a shunt that drains fluid out of the brain. Ordinary shunts are commonly used by patients suffering from severe excess pressure in the brain due to hydrocephalus or brain injury.

"A serious problem with shunts is that they may malfunction or become obstructed. The symptoms include a severe headache, but can be confusing, particularly when patients are small children," said Thomas. Such uncertainty can lead to the performance of unnecessary and unpleasant surgical procedures or, alternatively, to the postponement of what could be life-saving medical interventions.

"The technology will enable patients and physicians to determine whether cerebrospinal fluid flow is in fact, impaired," added Farrow. The device will also allow those involved to determine better what medical procedures should be performed

The NJIT SmartShunt includes a set of components that are geared toward reducing the potential for shunt obstruction. It is designed to have a lifetime of more than a decade because it needs no internal power. "The SmartShunt will also be a valuable new tool for research into what extent diet, motion and medication of patients can improve the pressure and flow of the fluid in the brain," Thomas added.

The NJIT team has been working on this device since September 2004 with grants from New Jersey Commission on Science and
'/>"/>

Contact: Sheryl Weinstein
973-596-3436
New Jersey Institute of Technology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. NACDD Receives Two-Year Grant From Merck & Co., Inc. to Improve Diabetes Education
2. Dr Yaghouti of Global Laser Vision Receives Patient's Choice Award for 2009
3. UT researcher receives $2.4 million to research obesity, high-risk pregnancy
4. BestMassage.com Receives Award for Customer Trust
5. Corporate Wellness Firm Limeade Receives SAS 70 Type II Report
6. Oridion Receives Frost & Sullivan's 2010 Customer Value Enhancement Award
7. Special Olympics Georgia Receives Grant from The Home Depot Foundation
8. NOVAVAX, Inc. Receives NASDAQ Non-Compliance Letter
9. WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility
10. Verdan Receives Patent on Crystal Deodorant Spray
11. Thomas E. Mower Meets With Dalai Lama; Receives Prestigious Champion Award from Whole Child International
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 2014 The regional economy is about ... is on the grow again. The plant will ... 2016 to boost production of the popular Highlander midsize ... overall investment to $4 billion. This step allows Toyota ... additional flexibility to adjust its product mix to meet ...
(Date:8/22/2014)... Americans know little about how Ebola is transmitted and harbor ... United States, a new survey shows. About four in ... a major Ebola outbreak in the United States, and one-quarter ... get sick with the deadly virus in the next year, ... However, those opinions don,t match reality, the Harvard researchers ...
(Date:8/22/2014)... Las Vegas, NV (PRWEB) August 22, 2014 ... that teaches readers how they can use natural methods ... for years has caught the attention of Shane Michaels, ... only a condition that affects the skin, it can ... suffer from it,” reports Michaels. “The intense itching and ...
(Date:8/22/2014)... Epidermal growth factor receptor (EGFR) mutations found in ... of advanced non-small cell lung cancer (NSCLC) patients correlates ... DNA. , EGFR tyrosine kinase inhibitor (TKI) therapy is ... NSCLC, but the standard for determining mutation status is ... be limited or not available. A more abundant and ...
(Date:8/22/2014)... August 22, 2014 Advancements in ... some clinical applications due to their cost-effectiveness, non-invasiveness, ... innovations in ultrasound, such as the evolution of ... to keep the market moving throughout 2014 and ... can enhance not only the point-of-care (POC) testing ...
Breaking Medicine News(10 mins):Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3
... FAIRFAX, Va., Sept. 18 The American Society,for Therapeutic ... growing staff; Barbara Muth is ASTRO,s new director of ... policy analyst., Ms. Muth brings nearly 20 years ... she worked with the American Red Cross for,eight years ...
... HOUSTON, Sept. 18 Today US Oncology, Inc., ... network,announced the appointment of Michael A. Sicuro as ... position Sicuro will lead and manage,the finance function ... financial,analytical, operational, and transactional issues, including accounting,financial reporting, ...
... claim that internationally adopted children can undergo puberty at ... variety of health risks as adults: abdominal obesity, hypertension, ... are internationally adopted children really more at risk? , ... their living conditions up until their adoption," says Hlne ...
... complication of severe burns. Injury to GI function, ... initiator as well as a stimulator for occurrence ... organ dysfunction syndrome following severe burns. With the ... the stereotype of clinical treatment in recent 30 ...
... present brief clinical report showed that Contrast-enhanced ... agent, Sonazoid, can allow surgeons to investigate ... to find new metastases intraoperatively. , ,Contrast-enhanced ... conventional IOUS to identify new occult lesions ...
... an essential role in filling the gap of transplants ... Considering that living related donors are healthy individuals at ... return to quality of life. , A research article ... World Journal of Gastroenterology addresses this question. ...
Cached Medicine News:Health News:ASTRO Names New Research Director, Health Policy Analyst 2Health News:US Oncology Appoints Michael A. Sicuro Executive Vice President and Chief Financial Officer 2Health News:Strategies for preventing gastrointestinal complications in severely burned patients 2Health News:An analysis of the surgical and perioperative complications in right hepatectomies 2
(Date:8/21/2014)...  Vermillion, Inc. (NASDAQ: VRML ), a ... health, has appointed Holly B. Bauzon as ... Ms. Bauzon has a proven track record in both ... services companies. She has more than 20 years of ... held the position of Director, Lab Services Sales and ...
(Date:8/21/2014)... YORK , Aug. 21, 2014  Publicis Groupe ... Shannon Hartley , Managing Partner and Healthcare Industry Group ... PharmaVoice 100, which recognizes the most inspiring people in ... are leaders in research and development, marketing, technology, creativity, ... agency in 2006 as a partner in its leading ...
(Date:8/21/2014)... 2014 /PRNewswire-iReach/ -- Inc. magazine today ... third straight year, No. 349 in Health on ... of the nation,s fastest-growing private companies. The list ... important segment of the economy—America,s independent entrepreneurs. Companies ... LinkedIn, Zillow, and many other well-known names gained ...
Breaking Medicine Technology:Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2Shannon Hartley Shines in PharmaVOICE 100 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3
... 2, 2010 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Agency (MHRA) in the UK has completed review of the ... acceptance for BMN 673 for genetically-defined cancers.  The company expects ... of 2011. "BMN 673 has been proven to ...
... THOUSAND OAKS, Calif., Dec. 2, 2010 Amgen (Nasdaq: ... from several key Nplate® (romiplostim) studies at the 52nd Annual ... Dec. 4-7, 2010, in Orlando, Fla. Results from six studies ... purpura (ITP) add to the growing body of data supporting ...
Cached Medicine Technology:MHRA Completes Review of CTA and Issues Notice of Acceptance for BMN 673 for Genetically-Defined Cancers 2MHRA Completes Review of CTA and Issues Notice of Acceptance for BMN 673 for Genetically-Defined Cancers 3Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 2Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 3Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 4Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 5Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 6Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 7Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 8Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 9Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 10Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 11Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 12Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 13Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 14Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting 15
Used to introduce large devices for vascular intervention....
Used for the introduction of catheters, balloons and other vascular devices....
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Sheath Introducer featuring patented SLIX Valve, rotating collar, kink-resistant cannula and atraumatic tip transitions....
Medicine Products: